黄连素在肠道疾病治疗中的研究进展
Research Progress of Berberine in Treatment of Intestinal Diseases
DOI: 10.12677/acm.2024.14112838, PDF,    科研立项经费支持
作者: 庞奇梦, 刘治花：西安医学院研究生工作部，陕西 西安；陈 敏：空军军医大学西京医院消化内科，陕西 西安；时永全*：西安医学院研究生工作部，陕西 西安；空军军医大学西京医院消化内科，陕西 西安
关键词: 黄连素；肠易激综合征；炎症性肠病；结直肠癌；Berberine； Irritable Bowel Syndrome； Inflammatory Bowel Disease； Colorectal Cancer
摘要: 黄连素具有广泛的生物学活性，包括但不限于抗炎、抗感染、调节肠道微生态以及抗肿瘤生长等效应。本文就黄连素在肠易激综合征、炎症性肠病及结直肠癌等肠道疾病治疗中的研究进展进行综述，以期为其临床应用提供参考。
Abstract: Berberine has multiple biological activities, such as anti-inflammation, anti-infection, regulating intestinal microbiota and anti-tumour effects. This review summarizes the research progress of berberine in the treatment of irritable bowel syndrome, inflammatory bowel disease and colorectal cancer. It provides theoretical foundation for clinical practice of berberine in those intestinal diseases.
文章引用：庞奇梦, 刘治花, 陈敏, 时永全. 黄连素在肠道疾病治疗中的研究进展[J]. 临床医学进展, 2024, 14(11): 15-20. https://doi.org/10.12677/acm.2024.14112838

参考文献

[1] Song, D., Hao, J. and Fan, D. (2020) Biological Properties and Clinical Applications of Berberine. Frontiers of Medicine, 14, 564-582. [Google Scholar] [CrossRef] [PubMed]
[2] Black, C.J. and Ford, A.C. (2020) Global Burden of Irritable Bowel Syndrome: Trends, Predictions and Risk Factors. Nature Reviews Gastroenterology & Hepatology, 17, 473-486. [Google Scholar] [CrossRef] [PubMed]
[3] 刘良浩, 蒋志滨, 于海洋, 等. 黄连素缓解肠易激综合征作用机制的研究进展[J]. 中国病理生理杂志, 2022, 38(5): 944-948.
[4] Lu, Y., Huang, J., Zhang, Y., Huang, Z., Yan, W., Zhou, T., et al. (2021) Therapeutic Effects of Berberine Hydrochloride on Stress-Induced Diarrhea-Predominant Irritable Bowel Syndrome Rats by Inhibiting Neurotransmission in Colonic Smooth Muscle. Frontiers in Pharmacology, 12, Article 596686. [Google Scholar] [CrossRef] [PubMed]
[5] Chen, C., Lu, M., Pan, Q., Fichna, J., Zheng, L., Wang, K., et al. (2015) Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner. PLOS ONE, 10, e0145556. [Google Scholar] [CrossRef] [PubMed]
[6] Yu, Z., Cen, Y., Wu, B., Wei, C., Xiong, F., Li, D., et al. (2019) Berberine Prevents Stress-Induced Gut Inflammation and Visceral Hypersensitivity and Reduces Intestinal Motility in Rats. World Journal of Gastroenterology, 25, 3956-3971. [Google Scholar] [CrossRef] [PubMed]
[7] Wade, U., Pascual-Figal, D.A., Rabbani, F., Ernst, M., Albert, A., Janssens, I., et al. (2024) The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study. Nutrients, 16, Article 1204. [Google Scholar] [CrossRef] [PubMed]
[8] Chen, C., Tao, C., Liu, Z., Lu, M., Pan, Q., Zheng, L., et al. (2015) A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea‐Predominant Irritable Bowel Syndrome. Phytotherapy Research, 29, 1822-1827. [Google Scholar] [CrossRef] [PubMed]
[9] Park, J. and Cheon, J.H. (2021) Incidence and Prevalence of Inflammatory Bowel Disease across Asia. Yonsei Medical Journal, 62, 99-108. [Google Scholar] [CrossRef] [PubMed]
[10] Bruner, L.P., White, A.M. and Proksell, S. (2023) Inflammatory Bowel Disease. Primary Care: Clinics in Office Practice, 50, 411-427. [Google Scholar] [CrossRef] [PubMed]
[11] Colgan, S.P. and Taylor, C.T. (2010) Hypoxia: An Alarm Signal during Intestinal Inflammation. Nature Reviews Gastroenterology & Hepatology, 7, 281-287. [Google Scholar] [CrossRef] [PubMed]
[12] Iborra, M., Moret, I., Rausell, F., Bastida, G., Aguas, M., Cerrillo, E., et al. (2011) Role of Oxidative Stress and Antioxidant Enzymes in Crohn’s Disease. Biochemical Society Transactions, 39, 1102-1106. [Google Scholar] [CrossRef] [PubMed]
[13] Candellone, A., Cerquetella, M., Girolami, F., Badino, P. and Odore, R. (2020) Acute Diarrhea in Dogs: Current Management and Potential Role of Dietary Polyphenols Supplementation. Antioxidants, 9, Article 725. [Google Scholar] [CrossRef] [PubMed]
[14] Wan, X., Chen, X., Liu, L., Zhao, Y., Huang, W., Zhang, Q., et al. (2013) Berberine Ameliorates Chronic Kidney Injury Caused by Atherosclerotic Renovascular Disease through the Suppression of NFκB Signaling Pathway in Rats. PLOS ONE, 8, e59794. [Google Scholar] [CrossRef] [PubMed]
[15] Neyrinck, A.M., Sánchez, C.R., Rodriguez, J., Cani, P.D., Bindels, L.B. and Delzenne, N.M. (2021) Prebiotic Effect of Berberine and Curcumin Is Associated with the Improvement of Obesity in Mice. Nutrients, 13, Article 1436. [Google Scholar] [CrossRef] [PubMed]
[16] Chae, S., Jeong, I., Choi, D., Oh, J. and Ahn, Y. (1999) Growth-Inhibiting Effects of Coptisjaponica Root-Derived Isoquinoline Alkaloids on Human Intestinal Bacteria. Journal of Agricultural and Food Chemistry, 47, 934-938. [Google Scholar] [CrossRef] [PubMed]
[17] Čerňáková, M. and Košťálová, D. (2002) Antimicrobial Activity of Berberine—A Constituent of Mahonia aquifolium. Folia Microbiologica, 47, 375-378. [Google Scholar] [CrossRef] [PubMed]
[18] Yang, T., Qin, N., Liu, F., Zhao, Y., Liu, W. and Fan, D. (2024) Berberine Regulates Intestinal Microbiome and Metabolism Homeostasis to Treat Ulcerative Colitis. Life Sciences, 338, Article 122385. [Google Scholar] [CrossRef] [PubMed]
[19] Yu, H., Zhang, S., Li, R., Ma, C., Zhang, Q., Xia, F., et al. (2024) Berberine Alleviates Inflammation and Suppresses PLA2-COX-2-PGE2-EP2 Pathway through Targeting Gut Microbiota in DSS-Induced Ulcerative Colitis. Biochemical and Biophysical Research Communications, 695, Article 149411. [Google Scholar] [CrossRef] [PubMed]
[20] 李春霖, 李时超, 贾英田, 等. 基于JAK/STAT信号通路探究黄连素对溃疡性结肠炎小鼠结肠皮细胞凋亡作用[J]. 中国药理学通报, 2023, 39(5): 938-945.
[21] Yan, F., Wang, L., Shi, Y., Cao, H., Liu, L., Washington, M.K., et al. (2012) Berberine Promotes Recovery of Colitis and Inhibits Inflammatory Responses in Colonic Macrophages and Epithelial Cells in DSS-Treated Mice. American Journal of Physiology-Gastrointestinal and Liver Physiology, 302, G504-G514. [Google Scholar] [CrossRef] [PubMed]
[22] Dong, Y., Fan, H., Zhang, Z., Jiang, F., Li, M., Zhou, H., et al. (2022) Berberine Ameliorates DSS-Induced Intestinal Mucosal Barrier Dysfunction through Microbiota-Dependence and Wnt/β-Catenin Pathway. International Journal of Biological Sciences, 18, 1381-1397. [Google Scholar] [CrossRef] [PubMed]
[23] Li, H., Feng, C., Fan, C., Yang, Y., Yang, X., Lu, H., et al. (2020) Intervention of Oncostatin M-Driven Mucosal Inflammation by Berberine Exerts Therapeutic Property in Chronic Ulcerative Colitis. Cell Death & Disease, 11, Article No. 271. [Google Scholar] [CrossRef] [PubMed]
[24] Xu, L., Zhang, Y., Xue, X., Liu, J., Li, Z., Yang, G., et al. (2020) A Phase I Trial of Berberine in Chinese with Ulcerative Colitis. Cancer Prevention Research, 13, 117-126. [Google Scholar] [CrossRef] [PubMed]
[25] 竺添雨, 王亚东, 孔弘伟. 盐酸小檗碱片联合美沙拉嗪治疗远端溃疡性结肠炎的临床研究[J]. 现代药物与临床, 2018, 33(12): 3183-3186.
[26] Liu, Q., Tang, J., Chen, S., Hu, S., Shen, C., Xiang, J., et al. (2022) Berberine for Gastric Cancer Prevention and Treatment: Multi-Step Actions on the Correa’s Cascade Underlie Its Therapeutic Effects. Pharmacological Research, 184, Article 106440. [Google Scholar] [CrossRef] [PubMed]
[27] Vlavcheski, F., O’Neill, E.J., Gagacev, F. and Tsiani, E. (2022) Effects of Berberine against Pancreatitis and Pancreatic Cancer. Molecules, 27, Article 8630. [Google Scholar] [CrossRef] [PubMed]
[28] Rauf, A., Abu-Izneid, T., Khalil, A.A., Imran, M., Shah, Z.A., Emran, T.B., et al. (2021) Berberine as a Potential Anticancer Agent: A Comprehensive Review. Molecules, 26, Article 7368. [Google Scholar] [CrossRef] [PubMed]
[29] Zhu, C., Li, K., Peng, X., Yao, T., Wang, Z., Hu, P., et al. (2022) Berberine a Traditional Chinese Drug Repurposing: Its Actions in Inflammation-Associated Ulcerative Colitis and Cancer Therapy. Frontiers in Immunology, 13, Article 1083788. [Google Scholar] [CrossRef] [PubMed]
[30] Yarmohammadi, F., Hayes, A.W. and Karimi, G. (2022) The Therapeutic Effects of Berberine against Different Diseases: A Review on the Involvement of the Endoplasmic Reticulum Stress. Phytotherapy Research, 36, 3215-3231. [Google Scholar] [CrossRef] [PubMed]
[31] Jiang, X., Jiang, Z., Jiang, M. and Sun, Y. (2022) Berberine as a Potential Agent for the Treatment of Colorectal Cancer. Frontiers in Medicine, 9, Article 886996. [Google Scholar] [CrossRef] [PubMed]
[32] Gong, C., Hu, X., Xu, Y., Yang, J., Zong, L., Wang, C., et al. (2020) Berberine Inhibits Proliferation and Migration of Colorectal Cancer Cells by Downregulation of GRP78. Anti-Cancer Drugs, 31, 141-149. [Google Scholar] [CrossRef] [PubMed]
[33] Nie, Q., Peng, W.W., Wang, Y., Zhong, L., Zhang, X. and Zeng, L. (2022) β-Catenin Correlates with the Progression of Colon Cancers and Berberine Inhibits the Proliferation of Colon Cancer Cells by Regulating the β-Catenin Signaling Pathway. Gene, 818, Article 146207. [Google Scholar] [CrossRef] [PubMed]
[34] Ruan, H., Zhan, Y.Y., Hou, J., Xu, B., Chen, B., Tian, Y., et al. (2017) Berberine Binds RXRα to Suppress β-Catenin Signaling in Colon Cancer Cells. Oncogene, 36, 6906-6918. [Google Scholar] [CrossRef] [PubMed]
[35] Zhang, Y., Liu, X., Yu, M., Xu, M., Xiao, Y., Ma, W., et al. (2020) Berberine Inhibits Proliferation and Induces G0/G1 Phase Arrest in Colorectal Cancer Cells by Downregulating IGF2BP3. Life Sciences, 260, Article 118413. [Google Scholar] [CrossRef] [PubMed]
[36] Liu, X., Ji, Q., Ye, N., Sui, H., Zhou, L., Zhu, H., et al. (2015) Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway. PLOS ONE, 10, e0123478. [Google Scholar] [CrossRef] [PubMed]
[37] Wang, Z., Dan, W., Zhang, N., Fang, J. and Yang, Y. (2023) Colorectal Cancer and Gut Microbiota Studies in China. Gut Microbes, 15, Article 2236364. [Google Scholar] [CrossRef] [PubMed]
[38] Feng, Y., Lu, J., Jiang, J., Wang, M., Guo, K. and Lin, S. (2024) Berberine: Potential Preventive and Therapeutic Strategies for Human Colorectal Cancer. Cell Biochemistry and Function, 42, e4033. [Google Scholar] [CrossRef] [PubMed]
[39] Chen, H., Ye, C., Cai, B., Zhang, F., Wang, X., Zhang, J., et al. (2022) Berberine Inhibits Intestinal Carcinogenesis by Suppressing Intestinal Pro-Inflammatory Genes and Oncogenic Factors through Modulating Gut Microbiota. BMC Cancer, 22, Article No. 566. [Google Scholar] [CrossRef] [PubMed]
[40] Sun, Q., Yang, H., Liu, M., Ren, S., Zhao, H., Ming, T., et al. (2022) Berberine Suppresses Colorectal Cancer by Regulation of Hedgehog Signaling Pathway Activity and Gut Microbiota. Phytomedicine, 103, Article 154227. [Google Scholar] [CrossRef] [PubMed]
[41] Chen, Y., Gao, Q., Zou, T., Wang, B., Liu, S., Sheng, J., et al. (2020) Berberine versus Placebo for the Prevention of Recurrence of Colorectal Adenoma: A Multicentre, Double-Blinded, Randomised Controlled Study. The Lancet Gastroenterology & Hepatology, 5, 267-275. [Google Scholar] [CrossRef] [PubMed]

为你推荐